Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Xi'an No.3 Hospital

Clinical trials sponsored by Xi'an No.3 Hospital, explained in plain language.

Trials to join now! 1

Experimental CAR-T therapy targets Hard-to-Treat myeloma

Disease control Recruiting now

This early-stage trial is testing a new type of CAR-T cell therapy made from donated umbilical cord blood. The cells are designed to attack two targets (BCMA and CD19) on myeloma cancer cells. Up to 18 adults with relapsed or refractory multiple myeloma will receive the treatment…

Phase 1 • Sponsor: Xi'an No.3 Hospital • Aim: Disease control

Last updated Jun 27, 2026 07:59 UTC